Carroll Child

1.3k total citations
16 papers, 1.0k citations indexed

About

Carroll Child is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Carroll Child has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 9 papers in Epidemiology and 3 papers in Virology. Recurrent topics in Carroll Child's work include HIV/AIDS drug development and treatment (7 papers), Mycobacterium research and diagnosis (6 papers) and Tuberculosis Research and Epidemiology (4 papers). Carroll Child is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), Mycobacterium research and diagnosis (6 papers) and Tuberculosis Research and Epidemiology (4 papers). Carroll Child collaborates with scholars based in United States. Carroll Child's co-authors include John P. Matts, Sharon Mannheimer, Margaret A. Chesney, Gerald Friedland, Albert W. Wu, Richard Hafner, Gerald Friedland, Laurie Andrews, Edward V. Morse and Barry Schmetter and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Carroll Child

15 papers receiving 966 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carroll Child United States 9 844 392 252 216 186 16 1.0k
Natasha Press Canada 13 825 1.0× 431 1.1× 377 1.5× 227 1.1× 119 0.6× 25 1.1k
V. Massari France 15 594 0.7× 417 1.1× 224 0.9× 112 0.5× 133 0.7× 48 933
Shannon Hader United States 19 949 1.1× 670 1.7× 260 1.0× 115 0.5× 334 1.8× 33 1.1k
Richard Conviser United States 13 805 1.0× 564 1.4× 171 0.7× 172 0.8× 269 1.4× 31 949
Wayne T. Dodge United States 5 493 0.6× 252 0.6× 121 0.5× 126 0.6× 190 1.0× 5 657
Angela Cescon Canada 15 572 0.7× 382 1.0× 144 0.6× 161 0.7× 180 1.0× 21 788
Jonathan Shuter United States 20 855 1.0× 399 1.0× 271 1.1× 352 1.6× 326 1.8× 74 1.5k
Leon Regensberg South Africa 9 1.2k 1.4× 304 0.8× 494 2.0× 176 0.8× 337 1.8× 15 1.2k
Jessica H. Oyugi United States 12 801 0.9× 259 0.7× 326 1.3× 100 0.5× 256 1.4× 15 999
Katherine Heath Canada 22 1.3k 1.6× 827 2.1× 629 2.5× 477 2.2× 248 1.3× 47 2.0k

Countries citing papers authored by Carroll Child

Since Specialization
Citations

This map shows the geographic impact of Carroll Child's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carroll Child with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carroll Child more than expected).

Fields of papers citing papers by Carroll Child

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carroll Child. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carroll Child. The network helps show where Carroll Child may publish in the future.

Co-authorship network of co-authors of Carroll Child

This figure shows the co-authorship network connecting the top 25 collaborators of Carroll Child. A scholar is included among the top collaborators of Carroll Child based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carroll Child. Carroll Child is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Doyle, Kristian P., et al.. (2025). Arterial assessment of the lower limb and foot: perceived benefits and disadvantages of current methods in contemporary practice. Huddersfield Research Portal (University of Huddersfield). 4(4). 190–198.
2.
Mannheimer, Sharon, Edward V. Morse, John P. Matts, et al.. (2006). Sustained Benefit From a Long-Term Antiretroviral Adherence Intervention. JAIDS Journal of Acquired Immune Deficiency Syndromes. 43(Supplement 1). S41–S47. 88 indexed citations
3.
Mannheimer, Sharon, John P. Matts, Margaret A. Chesney, et al.. (2004). Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care. 17(1). 10–22. 271 indexed citations
4.
Child, Carroll, et al.. (2003). Application of Quality Improvement Theory and Process in a National Multicenter HIV/AIDS Clinical Trials Network. Quality Management in Health Care. 12(2). 89–96. 2 indexed citations
5.
Mannheimer, Sharon, Gerald Friedland, John P. Matts, Carroll Child, & Margaret A. Chesney. (2002). The Consistency of Adherence to Antiretroviral Therapy Predicts Biologic Outcomes for Human Immunodeficiency Virus–Infected Persons in Clinical Trials. Clinical Infectious Diseases. 34(8). 1115–1121. 416 indexed citations
6.
Benson, Constance A., Paige L. Williams, David L. Cohn, et al.. (2000). Clarithromycin or Rifabutin Alone or in Combination for Primary Prophylaxis ofMycobacterium aviumComplex Disease in Patients with AIDS: A Randomized, Double‐Blind, Placebo‐Controlled Trial. The Journal of Infectious Diseases. 181(4). 1289–1297. 62 indexed citations
7.
Cohen, Misha, et al.. (2000). Use of a chinese herbal medicine for treatment of hiv-associated pathogen-negative diarrhea. PubMed. 2(2-3). 79–84. 8 indexed citations
8.
Cohn, David L., Evelyn J. Fisher, James S. Hodges, et al.. (1999). A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients. 67. 1 indexed citations
9.
Cohn, David L., Evelyn J. Fisher, James S. Hodges, et al.. (1999). A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: Excess mortality associated with high-dose clarithromycin. 67. 520–521. 1 indexed citations
10.
11.
Northfelt, Donald W., et al.. (1995). Continuous Low-Dose Interferon-?? Therapy for HIV-Related Immune Thrombocytopenic Purpura. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 8(1). 45???50–45???50. 8 indexed citations
12.
Jacobson, Mark Z., C. Lynn Besch, Carroll Child, et al.. (1994). Primary Prophylaxis with Pyrimethamine for Toxoplasmic Encephalitis in Patients with Advanced Human Immunodeficiency Virus Disease: Results of a Randomized Trial. The Journal of Infectious Diseases. 169(2). 384–394. 40 indexed citations
13.
Abrams, Donald I., et al.. (1993). Clofazimine as Prophylaxis for Disseminated Mycobacterium avium Complex Infection in AIDS. The Journal of Infectious Diseases. 167(6). 1459–1463. 20 indexed citations
14.
Jacobson, Mark Z., Carroll Child, C. Lynn Besch, et al.. (1992). Toxicity of clindamycin as prophylaxis for AIDS-associated toxoplasmic encephalitis. The Lancet. 339(8789). 333–334. 30 indexed citations
15.
Jacobson, Mark Z., C. Lynn Besch, Carroll Child, et al.. (1991). Clinical programs for clinical research on AIDS: Description of a randomized prospective study of clindamycin versus pyrimethamine for prevention ofToxoplasma gondii infection. European Journal of Clinical Microbiology & Infectious Diseases. 10(3). 195–198. 4 indexed citations
16.
Torseth, John W., Scott Harkonen, Carroll Child, et al.. (1989). Evaluation of the Antiviral Effect of Rifabutin in AIDS-Related Complex. The Journal of Infectious Diseases. 159(6). 1115–1118. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026